Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case Study
ConclusionThe checklist can help increase transparency of cost calculation and improve future comparison across studies. (Source: PharmacoEconomics)
Source: PharmacoEconomics - March 26, 2024 Category: Health Management Source Type: research
Correction: Comparing the Psychometric Performance of Generic Paediatric Health ‑Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 25, 2024 Category: Health Management Source Type: research
Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 18, 2024 Category: Health Management Source Type: research
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review
ConclusionsAlthough the reporting of economic models in NSCLC harboring EGFR mutations is generally good, many of these studies lacked sufficient reporting of justification for structural choices, performing extensive sensitivity analyses and validation in economic evaluations. In resolving such gaps, the validity of future models can be increased to guide healthcare decision making in rare indications. (Source: PharmacoEconomics)
Source: PharmacoEconomics - March 15, 2024 Category: Health Management Source Type: research
Reply to Comment on “A Framework for Fair Pricing of Medicines”
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 13, 2024 Category: Health Management Source Type: research
Comment on: A Framework for the Fair Pricing of Medicines
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 13, 2024 Category: Health Management Source Type: research
Reply to Comment on “A Framework for Fair Pricing of Medicines”
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 13, 2024 Category: Health Management Source Type: research
Comment on: A Framework for the Fair Pricing of Medicines
(Source: PharmacoEconomics)
Source: PharmacoEconomics - March 13, 2024 Category: Health Management Source Type: research
Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists ’ and Urologists’ Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries
ConclusionWhile average sample results were consistent with those of prior DCEs, this study found heterogeneity in clinician preferences within and across countries, highlighting the diversity in clinician decision making in oncology. (Source: PharmacoEconomics)
Source: PharmacoEconomics - March 12, 2024 Category: Health Management Source Type: research
